Regulators are moving from "what AI does the company use?" to "when an AI system takes a consequential action, can you prove a real, authorized human stood behind it?" Orzyn is the control that produces that proof — a verifiable, injection-resistant record at the point of action. Presence, not identity. No biometric stored.
FINRA's 2026 Regulatory Oversight Report tells firms to establish governance over generative AI and to supervise AI-driven activity, and its Rule 2210 modernization (Notice 26-14) reflects the same direction.
Orzyn produces a verifiable record that an authorized human stood behind a consequential AI-assisted action — evidence you can feed into your supervisory system and audit trail.
The SEC is weighing standardized AI-governance and risk-management disclosure (rulemaking petition File No. 4-882), modeled on its cybersecurity-disclosure rule.
Orzyn gives you a concrete, disclosable governance control: verifiable human accountability for high-consequence AI-driven actions — the AI analogue of the internal-control and incident disclosures you already make.
Safeguard protected health information and ensure authorized human involvement in clinical systems and actions.
Orzyn proves a real, authorized clinician was present at the consequential clinical action. A Business Associate Agreement (BAA) is available, and Orzyn stores no biometric templates — minimizing PHI in scope.
Two-factor authentication and provider identity-proofing at the point of electronically prescribing controlled substances.
Orzyn adds injection-resistant proof that a real, present prescriber authorized the specific script — resistant to the deepfake and virtual-camera attacks that credential-based factors don't test for.
Article 14 requires effective human oversight of high-risk AI systems.
Orzyn provides evidence of human authorization at the consequential action — supporting the human-oversight obligation with a record that holds up after the fact.
The NIST AI Risk Management Framework (Govern / Map / Measure / Manage) and NIST's emerging AI-agent standards emphasize accountability for autonomous actions.
Orzyn supplies a per-action human-of-record that operationalizes the accountability these frameworks call for — attached to the action and the human, not the model.
State biometric laws such as Illinois BIPA, and the GDPR, impose strict duties on collecting and storing biometric data.
Orzyn stores no biometric templates — it proves presence, not identity — which reduces your biometric-compliance scope by design rather than adding to it.
New laws (TAKE IT DOWN Act; the NO FAKES Act, advancing) turn on verifying requests and rights-holders.
Orzyn's verified human-presence attestations can strengthen the validity of a request or a rights-holder's claim — resistant to synthetic or injected impersonation.
An honest note on scope. Orzyn is one control among the many your program operates. It supports and evidences your obligations; it does not by itself guarantee compliance, and nothing on this page is legal advice. Regulations change and apply differently to every organization — confirm how Orzyn fits your specific obligations with your own counsel and compliance team.
Tell us your regulators and your highest-consequence AI action. We'll show you exactly what Orzyn evidences, and where it fits your program.
Book a walkthroughFINRA's 2026 report tells firms to govern and supervise generative AI. Orzyn produces a verifiable, injection-resistant record that a real, authorized human stood behind a consequential AI-assisted action — evidence for your supervisory system. Orzyn is one control among your own and does not by itself guarantee compliance.
As the SEC weighs standardized AI-governance disclosure (petition File No. 4-882), Orzyn gives you a concrete, disclosable control: verifiable human accountability for high-consequence AI-driven actions, analogous to internal-control and cybersecurity-incident disclosures.
Orzyn proves a real, authorized clinician was present at a consequential clinical action. A BAA is available, and Orzyn stores no biometric templates, minimizing PHI in scope.
Article 14 of the EU AI Act requires effective human oversight of high-risk AI. Orzyn provides evidence of human authorization at the consequential action, supporting that obligation.
Orzyn stores no biometric templates — presence, not identity — which reduces your biometric-compliance scope by design. Confirm your specific obligations with counsel.